During the past decade, Higashi Sapporo Neurology and Neurosurgery Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Higashi Sapporo Neurology and Neurosurgery Clinic" are "Migraine" (2 trials). Many other conditions were trialed in "Higashi Sapporo Neurology and Neurosurgery Clinic" in a lesser frequency.

Most popular intervention types in "Higashi Sapporo Neurology and Neurosurgery Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Rimegepant" (1 trials), "Rimegepant 25 MG" (1 trials) and "Rimegepant 75 MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Higashi Sapporo Neurology and Neurosurgery Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Higashi Sapporo Neurology and Neurosurgery Clinic". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Higashi Sapporo Neurology and Neurosurgery Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Higashi Sapporo Neurology and Neurosurgery Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".